Equities

Natural Health Trends Corp

Natural Health Trends Corp

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (USD)6.91
  • Today's Change0.04 / 0.58%
  • Shares traded3.00
  • 1 Year change+25.64%
  • Beta0.7982
Data delayed at least 15 minutes, as of May 31 2024 21:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Natural Health Trends Corp is a company mainly engaged in the direct-selling and e-commerce business. The Company is engaged in the supply of the products in six distinct categories: wellness, herbal, beauty, lifestyle, home, and daily. Wellness products include dietary and nutritional supplements, vitamins and minerals. Herbal products include herbal supplements. Beauty products include facial skin care as well as hand and body care. Lifestyle products include supplements and topical gels. Home products include home appliances such as air purifiers and others. Daily products include oral care, hair care, and body care.

  • Revenue in USD (TTM)43.01m
  • Net income in USD499.00k
  • Incorporated2005
  • Employees138.00
  • Location
    Natural Health Trends CorpUnits 1205-07, 12F, Mira Place Tower A,132 Nathan Road, Tsimshatsui, KowloonKOWLOON Hong KongHKG
  • Phone+852 31070800
  • Fax+1 3 026555049
  • Websitehttps://www.naturalhealthtrendscorp.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Navamedic ASA48.78m314.80k56.31m45.00179.972.6538.811.150.18840.188429.7512.821.133.396.2411,377,690.000.72850.0391.120.063538.8838.330.64530.0380.55431.850.4074--33.9822.72-88.77-2.5359.60--
Kim Forest Enterprise Co Ltd12.82m-4.12m57.21m----3.28--4.46-2.85-2.858.8911.290.49863.344.31---16.02-0.8245-19.78-1.0613.1531.99-32.14-1.251.19-82.430.2664---38.1112.36-341.58---8.51--
Sinco Pharmaceuticals Holdings Ltd351.17m5.86m61.10m278.0010.440.70377.560.1740.02250.02251.350.3341.5322.605.739,876,659.002.566.486.5520.2212.7314.791.673.861.0828.200.28597.2111.8221.66-39.03--123.63--
Hyphens Pharma International Ltd126.25m6.34m62.93m440.009.931.357.470.49840.02770.02770.55130.20371.454.654.89387,715.907.298.3512.1014.0136.2937.065.035.651.35--0.093933.005.107.12-24.529.63-18.709.35
Harima-Kyowa Co., LTD.391.46m8.94m72.29m197.007.980.46557.800.1847261.75261.7511,459.404,490.241.9123.795.51--4.364.395.705.8711.5711.732.282.232.22--0.013117.152.375.011.103.2534.303.44
Balaxi Pharmaceuticals Ltd28.91m-286.04k78.73m51.00--3.22--2.72-0.566-0.56646.7536.960.9691.374.47---0.958619.81-1.2227.3046.6735.46-0.989311.952.3626.610.0879---28.2877.76-105.19--5.11--
Natural Health Trends Corp.43.01m499.00k79.58m138.00159.112.02122.061.850.04340.04343.753.420.5822.24--311,695.700.6751-0.53980.9333-0.709974.3074.061.16-0.95712.77--0.00---10.60-25.5481.47-54.86-26.476.64
111 Inc - ADR2.04bn-51.74m100.95m1.52k------0.0495-0.6106-0.610624.07-1.044.809.6232.621,342,754.00-10.93-17.09---178.255.565.36-2.28-4.370.5234-19.990.4256--10.5952.955.80---7.89--
Pharmaniaga Berhad723.28m-16.45m110.23m3.78k------0.1524-0.0572-0.05722.55-0.20561.824.599.57---4.06-6.88---38.459.046.64-2.23-3.660.27621.371.29---3.027.3887.25--23.35--
Sopharma Trading AD960.10m17.49m111.21m2.73k6.361.473.130.11580.92010.920150.503.982.660.15867.16661,702.604.852.3914.877.8897.9898.091.821.010.6231185.950.6107--13.0213.26221.6727.863.70--
Data as of May 31 2024. Currency figures normalised to Natural Health Trends Corp's reporting currency: US Dollar USD

Institutional shareholders

10.11%Per cent of shares held by top holders
HolderShares% Held
Renaissance Technologies LLCas of 31 Mar 2024705.31k6.12%
BlackRock Fund Advisorsas of 31 Mar 2024112.21k0.97%
The Vanguard Group, Inc.as of 31 Mar 2024111.51k0.97%
Geode Capital Management LLCas of 31 Mar 202481.90k0.71%
Dimensional Fund Advisors LPas of 31 Mar 202464.18k0.56%
SSgA Funds Management, Inc.as of 31 Mar 202423.52k0.20%
G1 Execution Services LLCas of 31 Mar 202418.05k0.16%
Citadel Securities LLCas of 31 Mar 202417.56k0.15%
Northern Trust Investments, Inc.(Investment Management)as of 31 Mar 202415.89k0.14%
Bay Colony Advisory Group, Inc.as of 31 Mar 202414.24k0.12%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.